FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783825830> ?p ?o ?g. }

• W2783825830 endingPage "106" @default.
• W2783825830 startingPage "97" @default.
• W2783825830 abstract "Background Children of preschool age often have episodes of virus-associated wheeze, and research assessing efficacy of corticosteroids for paediatric wheeze exacerbations is inconclusive. Methods This non-inferiority, randomised, double-blind, placebo-controlled trial was to compare the efficacy of placebo versus oral prednisolone in children aged 24–72 months presenting with virus-associated wheeze at the paediatric emergency department of Princess Margaret Hospital in Perth, WA, Australia. Eligible participants were randomly assigned (1:1) using a computer-generated random number program to receive placebo or prednisolone (1 mg/kg per day) for 3 days. The primary outcome was total length of stay in hospital until ready for discharge. Following an analysis to test the hypothesis that placebo is non-inferior to prednisolone, a post-hoc superiority analysis was done to test the hypothesis that prednisolone was superior to placebo. A non-inferiority margin of 10% was used to establish non-inferiority. Efficacy analyses were on a modified intention-to-treat basis, whereby patients were excluded from the final efficacy analysis if consent was withdrawn, two doses of study drug were vomited, or paperwork was lost. All participants were included in safety analyses. This study is registered with the Australian and New Zealand Clinical Trials Registry, number ACTRN12612000394842. Findings Between June 11, 2012, and June 10, 2015, we screened 3727 patients for eligibility. 624 eligible patients were randomly assigned to treatment, and 605 patients were included in the modified intention-to-treat analysis (300 patients from the placebo group, 305 patients from the prednisolone group). The median length of stay until ready for discharge was longer in the placebo group (540 min [IQR 124–971]) than in the prednisolone group (370 min [121–709]); placebo was inferior to prednisolone. In the post-hoc superiority analysis of 605 patients, the unadjusted ratio of geometric mean for length of stay was 0·79 (95% CI 0·64–0·97; p=0·0227) for the prednisolone group relative to the placebo group. No serious adverse events were reported during the study or follow-up period. One child in the placebo group had a non-specific maculopapular rash, which resolved spontaneously. Two children (one from each group) were reported to be hyperactive during follow-up assessments. Interpretation Oral prednisolone had a clear benefit over placebo at reducing the length of stay in children presenting to a paediatric emergency department with virus-associated wheeze and was well tolerated. Funding Western Australian Department of Health." @default.
• W2783825830 created "2018-01-26" @default.
• W2783825830 creator A5010698070 @default.
• W2783825830 creator A5033670222 @default.
• W2783825830 creator A5047193815 @default.
• W2783825830 creator A5049775080 @default.
• W2783825830 date "2018-02-01" @default.
• W2783825830 modified "2023-10-14" @default.
• W2783825830 title "Oral prednisolone in preschool children with virus-associated wheeze: a prospective, randomised, double-blind, placebo-controlled trial" @default.
• W2783825830 cites W1974223115 @default.
• W2783825830 cites W1977122716 @default.
• W2783825830 cites W1978203735 @default.
• W2783825830 cites W1978811563 @default.
• W2783825830 cites W1980111566 @default.
• W2783825830 cites W2011241237 @default.
• W2783825830 cites W2013993424 @default.
• W2783825830 cites W2051154838 @default.
• W2783825830 cites W2095437242 @default.
• W2783825830 cites W2099621406 @default.
• W2783825830 cites W2108424007 @default.
• W2783825830 cites W2131502412 @default.
• W2783825830 cites W2131770075 @default.
• W2783825830 cites W2134902690 @default.
• W2783825830 cites W2151947874 @default.
• W2783825830 cites W2155687796 @default.
• W2783825830 cites W2168434614 @default.
• W2783825830 cites W2312397711 @default.
• W2783825830 doi "https://doi.org/10.1016/s2213-2600(18)30008-0" @default.
• W2783825830 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29373235" @default.
• W2783825830 hasPublicationYear "2018" @default.
• W2783825830 type Work @default.
• W2783825830 sameAs 2783825830 @default.
• W2783825830 citedByCount "36" @default.
• W2783825830 countsByYear W27838258302018 @default.
• W2783825830 countsByYear W27838258302019 @default.
• W2783825830 countsByYear W27838258302020 @default.
• W2783825830 countsByYear W27838258302021 @default.
• W2783825830 countsByYear W27838258302022 @default.
• W2783825830 countsByYear W27838258302023 @default.
• W2783825830 crossrefType "journal-article" @default.
• W2783825830 hasAuthorship W2783825830A5010698070 @default.
• W2783825830 hasAuthorship W2783825830A5033670222 @default.
• W2783825830 hasAuthorship W2783825830A5047193815 @default.
• W2783825830 hasAuthorship W2783825830A5049775080 @default.
• W2783825830 hasConcept C118552586 @default.
• W2783825830 hasConcept C126322002 @default.
• W2783825830 hasConcept C142724271 @default.
• W2783825830 hasConcept C168563851 @default.
• W2783825830 hasConcept C1862650 @default.
• W2783825830 hasConcept C187212893 @default.
• W2783825830 hasConcept C204787440 @default.
• W2783825830 hasConcept C27081682 @default.
• W2783825830 hasConcept C2776042228 @default.
• W2783825830 hasConcept C2776715498 @default.
• W2783825830 hasConcept C2778338976 @default.
• W2783825830 hasConcept C2780724011 @default.
• W2783825830 hasConcept C535046627 @default.
• W2783825830 hasConcept C71924100 @default.
• W2783825830 hasConceptScore W2783825830C118552586 @default.
• W2783825830 hasConceptScore W2783825830C126322002 @default.
• W2783825830 hasConceptScore W2783825830C142724271 @default.
• W2783825830 hasConceptScore W2783825830C168563851 @default.
• W2783825830 hasConceptScore W2783825830C1862650 @default.
• W2783825830 hasConceptScore W2783825830C187212893 @default.
• W2783825830 hasConceptScore W2783825830C204787440 @default.
• W2783825830 hasConceptScore W2783825830C27081682 @default.
• W2783825830 hasConceptScore W2783825830C2776042228 @default.
• W2783825830 hasConceptScore W2783825830C2776715498 @default.
• W2783825830 hasConceptScore W2783825830C2778338976 @default.
• W2783825830 hasConceptScore W2783825830C2780724011 @default.
• W2783825830 hasConceptScore W2783825830C535046627 @default.
• W2783825830 hasConceptScore W2783825830C71924100 @default.
• W2783825830 hasIssue "2" @default.
• W2783825830 hasLocation W27838258301 @default.
• W2783825830 hasLocation W27838258302 @default.
• W2783825830 hasOpenAccess W2783825830 @default.
• W2783825830 hasPrimaryLocation W27838258301 @default.
• W2783825830 hasRelatedWork W2026095104 @default.
• W2783825830 hasRelatedWork W2163643342 @default.
• W2783825830 hasRelatedWork W2199387204 @default.
• W2783825830 hasRelatedWork W2416994686 @default.
• W2783825830 hasRelatedWork W2510700473 @default.
• W2783825830 hasRelatedWork W2781109165 @default.
• W2783825830 hasRelatedWork W2783825830 @default.
• W2783825830 hasRelatedWork W4233016836 @default.
• W2783825830 hasRelatedWork W4238308949 @default.
• W2783825830 hasRelatedWork W4256514411 @default.
• W2783825830 hasVolume "6" @default.
• W2783825830 isParatext "false" @default.
• W2783825830 isRetracted "false" @default.
• W2783825830 magId "2783825830" @default.
• W2783825830 workType "article" @default.